An X-Waiver is the DEA-issued number that permits physicians, nurse practitioners, and physician assistants to treat patients with opioid use disorder (OUD) with buprenorphine, which is a highly effective medication to help our patients with OUD reduce or eliminate their opioid use, improve their health, and reduce the risk of opioid overdose. Attend full training live followed by online survey, or do half live and AFTER THE LIVE TRAINING, complete additional online training / quiz through the link sent by…

Finding Resources Where None Exist (Session 4) Modeled on the CA Bridge implementation Blueprint, this “Boot Camp” series will provide specialized training and networking opportunities for hospital champions. Sessions will focus on changing the standard of care for substance use disorders, including clinical guidance for medication for addiction treatment (MAT), and health equity for underrepresented populations. This series offers CME for physicians and self-reported hours for other clinicians. Register here.

A one-hour clinic will be held every fourth Monday from 12-1pm PT. The purpose of this one-hour web training is to provide physicians, nurses, and other health care providers an opportunity to 1) learn about medications for addiction treatment (MAT) as well as evidence-based practices in treating patients with OUD and 2) participate in case-based learning focused on medication-assisted treatment. Featured Facilitators and Experts: Thomas E. Freese, PhD, Gloria Miele, PhD – UCLA Integrated Substance Abuse Programs Cheryl Ho, MD…

An X-Waiver is the DEA-issued number that permits physicians, nurse practitioners, and physician assistants to treat patients with opioid use disorder (OUD) with buprenorphine, which is a highly effective medication to help our patients with OUD reduce or eliminate their opioid use, improve their health, and reduce the risk of opioid overdose. Attend full training live followed by online survey, or do half live and AFTER THE LIVE TRAINING, complete additional online training / quiz through the link sent by…

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…

Measuring and Communicating Success (Session 5) Modeled on the CA Bridge implementation Blueprint, this “Boot Camp” series will provide specialized training and networking opportunities for hospital champions. Sessions will focus on changing the standard of care for substance use disorders, including clinical guidance for medication for addiction treatment (MAT), and health equity for underrepresented populations. This series offers CME for physicians and self-reported hours for other clinicians. Register here.

An X-Waiver is the DEA-issued number that permits physicians, nurse practitioners, and physician assistants to treat patients with opioid use disorder (OUD) with buprenorphine, which is a highly effective medication to help our patients with OUD reduce or eliminate their opioid use, improve their health, and reduce the risk of opioid overdose. Attend full training live followed by online survey, or do half live and AFTER THE LIVE TRAINING, complete additional online training / quiz through the link sent by…

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…

A one-hour clinic will be held every fourth Monday from 12-1pm PT. The purpose of this one-hour web training is to provide physicians, nurses, and other health care providers an opportunity to 1) learn about medications for addiction treatment (MAT) as well as evidence-based practices in treating patients with OUD and 2) participate in case-based learning focused on medication-assisted treatment. Featured Facilitators and Experts: Thomas E. Freese, PhD, Gloria Miele, PhD – UCLA Integrated Substance Abuse Programs Cheryl Ho, MD…

The Provider Support Initiative (PSI) monthly webinars occur on the 2nd and 4th Tuesdays of each month 12-1PM (PT). The objective of this webinar series is to elevate evidence based clinical practices to prescribe buprenorphine for opioid use disorder and address management of complex patients with co-occurring disorders, co-morbidities, and/or co-occurring substance use. Content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American…